Voltarene

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Voltarene

This foundational section defines the medicine known as Voltarene, focusing strictly on its identity, composition, and general nature.

Property Description
Active ingredient Diclofenac (e.g., Sodium, Potassium, Diethylamine)
Form Tablet, Gel, Suppository, Solution, Patch
Pharmacological class Non-steroidal Anti-inflammatory Drug (NSAID)
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic Phenylacetic acid derivative

What Type of Medicine is Voltarene and What is Its Core Ingredient?

Voltarene is a globally recognized brand name for a medication whose active substance is Diclofenac, a compound that is entirely synthetic in origin and belongs to the phenylacetic acid chemical class. This medication is consistently classified as a Non-steroidal Anti-inflammatory Drug (NSAID), a class clinically recognized for its ability to reduce inflammation and pain. The medication is therefore fundamentally identified by its combined effects: it is analgesic (pain-relieving), anti-inflammatory (reduces swelling and redness), and antipyretic (fever-reducing).

Composition, Origin, and Available Forms

The core composition utilizes the Diclofenac molecule often formulated as different salts, such as Diclofenac Sodium or Diclofenac Potassium. These salts are stable forms of the same active drug, allowing it to be prepared for various routes of administration. Diclofenac is available across several fundamental dosage forms, including oral tablets (such as delayed-release tablets), topical gels (such as those using a diethylamine salt), and rectal suppositories. The topical gel formulation, a distinctive feature of the Voltarene product line, is designed for localized delivery, concentrating the active ingredient where the pain is felt, providing relief without requiring systemic circulation.

What is the General Therapeutic Purpose of Diclofenac?

The general therapeutic purpose of Diclofenac is to provide effective symptomatic relief by modulating the body's inflammatory and pain response. It operates by serving as a potent Cyclooxygenase (COX) inhibitor, a high-level mechanism principle that directly prevents the synthesis of prostaglandins. Prostaglandins are key chemical mediators in the body responsible for sensitizing nerves to pain and initiating swelling. These anti-inflammatory effects help ease discomfort by interrupting the body's inflammatory process, making it a standard option for general pain and inflammation management.

Regulatory References

  1. Diclofenac - StatPearls (NIH)
  2. Diclofenac Sodium Delayed-Release Tablets - FDA

What side effects are possible with Voltarene?

Voltarene: Possible Side Effects and Safety Information

Voltarene (diclofenac) is a Non-Steroidal Anti-Inflammatory Drug (NSAID) associated with significant, officially documented systemic risks. Usage should be limited to the lowest effective dose for the shortest duration to minimize potential adverse effects.

Serious and Clinically Significant Risks

  • Cardiovascular Thrombotic Events: Systemic diclofenac is associated with an increased risk of serious cardiovascular events including myocardial infarction (MI) and stroke, which can be fatal. This risk may increase with higher doses and longer duration of treatment. It is contraindicated in patients with established congestive heart failure (NYHA class II–IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.
  • Gastrointestinal (GI) Adverse Events: NSAIDs carry an increased risk of serious GI inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal and may occur without warning symptoms. Elderly patients are at greater risk for these serious events.
  • Severe Skin and Allergic Reactions: Serious skin reactions, including exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), and Toxic Epidermal Necrolysis (TEN), have been reported rarely and can be fatal. Anaphylactoid reactions may also occur, particularly in patients with a history of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.

General Adverse Reactions and Safety Considerations

Commonly reported adverse reactions include gastrointestinal symptoms (nausea, indigestion, abdominal pain), headache, and dizziness. Long-term administration has been associated with renal papillary necrosis and other renal injury, requiring caution in patients with impaired renal or hepatic function, heart failure, or dehydration. The drug is contraindicated in the last trimester of pregnancy due to the risk of premature closure of the fetal ductus arteriosus and potential fetal renal impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official government regulatory documents confirm that a suspected overdose of Voltarene (Diclofenac) requires immediate medical attention. This mandatory action is due to the potential for severe, life-threatening systemic toxicity. It is advised to contact emergency services or a poison control center immediately upon suspicion of over-exposure.

Documented Overdose Manifestations

Overdose presentations are primarily concentrated in the gastrointestinal and nervous systems. Documented symptoms include nausea, vomiting, diarrhea, abdominal pain, dizziness, drowsiness, and headache. Severe outcomes can involve gastrointestinal bleeding or perforation, which is listed as potentially fatal. Critical neurological effects such as seizures and, in very severe cases, coma are also officially noted.

Severe Complications and Management

Severe complications documented in regulatory sources include acute renal failure (little or no urine output) and systemic instability like hypotension (low blood pressure) and respiratory depression. The official label states that no specific antidote is known for Diclofenac toxicity. Management is therefore strictly symptomatic and supportive, which may involve procedures like administering activated charcoal or gastric lavage and continuous hospital monitoring of vital signs and organ function. Elderly patients and those with dehydration are identified as being at an increased risk for specific severe complications, such as gastrointestinal events and nephrotoxicity, respectively.

Therapeutic Uses of Voltarene

Voltarene (Diclofenac) is commonly used to relieve symptoms related to various inflammatory conditions.

What Voltarene Treats: Main Uses and Benefits

Voltarene is applied across domains where additional symptomatic support is needed for managing pain and inflammation. It is relevant for easing symptoms related to inflammatory or irritative states associated with both chronic conditions and acute, episodic events.

The medication is commonly used across conditions presenting with acute episodes, which includes managing osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, and is relevant for easing symptoms associated with acute or episodic changes like gout attacks, menstrual cramping, and certain migraine headaches. It is used for managing symptoms that may become intense or disruptive, such as persistent joint stiffness, localized swelling, and fever. This support assists with maintaining functional stability and supports the patient during difficult episodes by easing distress.

“The medication offers symptomatic relief that helps patients cope more steadily with difficult episodes and chronic symptom fluctuations.”

Quick Fact: Relief for Joint Stiffness The medication is commonly used to help manage morning stiffness and pain on movement, symptoms that interfere with daily functioning in patients with inflammatory joint disorders.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Diclofenac (Voltarene)

Regulatory documents define strict rules for who can and cannot use Voltarene (Diclofenac) based on health status and age.

Populations for whom use is contraindicated:

Condition / Status Classification
History of allergic reactions, asthma, or hives after taking aspirin or other NSAIDs Contraindicated
Active gastrointestinal bleeding, perforation, or peptic ulcer disease Contraindicated
Severe renal or severe hepatic failure Contraindicated
Established congestive heart failure (NYHA Class II-IV) or major vascular disease Contraindicated
Setting of coronary artery bypass graft (CABG) surgery Contraindicated
Third trimester of pregnancy (after 30 weeks gestation) Contraindicated

Age-Related Eligibility:

  • Adults are generally eligible for use under labeled conditions. Older adults require use with caution due to increased risks.
  • Pediatric use (children under 14) is typically not recommended for systemic forms, as safety and effectiveness are not established for many common indications.

Conditional Use:

  • Use is not recommended for women who are breastfeeding due to drug excretion into milk.
  • Patients with mild-to-moderate renal or hepatic impairment require use with caution and close monitoring.

What should I know about interactions with other medicines?

Voltarene’s officially documented interaction profile emphasizes constraints related to bleeding risk, renal function, and the alteration of drug exposure. The medication is strictly contraindicated for the treatment of pain following coronary artery bypass graft (CABG) surgery. Furthermore, co-administration with Aspirin or other systemic Non-steroidal Anti-inflammatory Drugs (NSAIDs) is not generally recommended due to the elevated risk of serious gastrointestinal (GI) adverse events.

Documented Interaction Patterns

  • Increased Bleeding Risk: The risk of serious GI bleeding is significantly increased when Voltarene is co-administered with medicines that interfere with hemostasis, including Anticoagulants, Antiplatelet Agents, Selective Serotonin Reuptake Inhibitors (SSRIs), and Systemic Corticosteroids. Concurrent consumption of Alcohol (Ethanol) also increases the risk of serious GI problems.
  • Efficacy and Renal Impact: Voltarene may reduce the antihypertensive and diuretic effects of medicines such as ACE Inhibitors, ARBs, and Diuretics. Co-administration of these combinations also increases the documented risk of renal impairment.
  • Exposure Alterations: Voltarene can cause an increase in the plasma concentrations of medicines like Lithium and Methotrexate, which may lead to potential toxicity. Conversely, co-administration with Voriconazole (a strong CYP2C9 inhibitor) is officially documented to significantly increase the overall exposure (Cmax and AUC) of Diclofenac itself.
  • Administration Constraints: The oral solution formulation must be administered on an empty stomach, as food may reduce its intended efficacy. Elderly patients are noted in official labeling to be at higher risk for serious GI adverse events when combining Voltarene with other interacting medicines.

Mechanism of Action

Blocking Prostaglandin Synthesis via COX Enzymes

Voltarene (Diclofenac) exerts its effects by fundamentally altering the body's chemical signaling pathways that generate eicosanoids. Its action is centered on the non-selective, competitive inhibition of the Cyclooxygenase (COX) enzyme isoforms, COX-1 and COX-2. Diclofenac reversibly binds to the enzyme's active site, physically preventing the conversion of Arachidonic Acid into prostaglandins. This action modifies the early molecular steps that shape systemic physiological outcomes.


Modulating Nociceptive Sensitivity and Thermoregulation

The consequence of reduced prostaglandin levels is twofold: it modulates the sensitivity of peripheral nociceptors to inflammatory mediators, and centrally, it suppresses the prostaglandin signal that acts upon the hypothalamic thermoregulatory center. This mechanism influences the activity within targeted pathways, contributing to the physiological consequences of altered nociceptive signal propagation and normalization of the hypothalamic temperature set-point.

Dosage and Administration Information

Voltarene administration is strictly governed by officially approved routes and dosage principles based on established guidelines. The active ingredient, diclofenac, is provided through diverse forms, including oral ingestion (as tablets, capsules, or powder), topical application (gel or solution), rectal suppositories, and parenteral injection (Intramuscular (IM) or Intravenous (IV)). This multi-route availability dictates a form-specific approach to use.

Systemic dosing is structured around precise numerical ranges. For most oral forms, the standard adult regimen involves doses that should not exceed a total maximum daily intake of 150 mg, which is often achieved through divided use two to four times per day. Certain extended-release formulations are designated for once-daily administration. The overarching administration principle is to use the lowest effective dose for the shortest duration possible, consistent with official label instructions.

Proper usage requires strict adherence to contextual intake rules. For example, specific oral dosage forms, such as the powder for oral solution, must be mixed with water and consumed on an empty stomach for optimal effect. Conversely, enteric-coated or extended-release tablets must be swallowed whole and must not be crushed, cut, or chewed to maintain their designed release profile. Parenteral administration via IV or IM injection is typically limited to acute, short-term use, generally not exceeding two consecutive days. Administration rules for specific populations, such as older adults, require starting treatment at the lowest feasible dose.

Recent Clinical Evidence

Voltarene, a brand name for the non-steroidal anti-inflammatory drug (NSAID) diclofenac, has been the subject of extensive clinical research focusing on its anti-inflammatory and analgesic properties across various formulations.

Efficacy in Common Pain Conditions

Clinical trials consistently support diclofenac's use for managing the signs and symptoms of inflammatory conditions such as osteoarthritis (OA) and rheumatoid arthritis (RA), as well as ankylosing spondylitis. Studies measuring outcomes like the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscale score have reported significant reductions in pain compared to baseline in participants with knee or hip OA.

For acute pain, research in areas like post-operative dental surgery and trauma-related pain suggests diclofenac may provide substantial pain relief. In comparisons with other common oral analgesics, some trials have indicated that diclofenac may achieve pain relief more quickly in certain acute scenarios, though overall efficacy over longer periods may be comparable.

Topical Formulations (Gels)

The topical gel formulation of diclofenac (Voltarene Emulgel) is supported by trials for the localized relief of pain associated with acute muscle and joint injuries, such as strains and sprains. Research suggests that topical application can be effective for localized OA of the knee and hand. Pooled data from randomized, double-blind trials indicate that topical diclofenac may offer comparable efficacy to some oral NSAIDs for OA pain and function improvement, potentially with fewer systemic adverse events due to lower systemic absorption.

Safety Considerations in Research

Research has highlighted important safety considerations associated with systemic NSAID use. Observational studies suggest that non-selective NSAIDs, including diclofenac, may be associated with an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke. This potential risk is noted to increase with higher dosage and longer duration of use. Additionally, all NSAIDs, including diclofenac, carry a risk of serious gastrointestinal events such as bleeding and ulceration, a risk that also increases with dose and duration.

Frequently Asked Questions (FAQ)

Common questions about Voltarene (FAQ)

Q: What is Voltarene typically used for besides arthritis?

A: Official regulatory documents list uses for symptomatic relief beyond chronic arthritis. Indications include conditions such as primary dysmenorrhea (menstrual pain). It is also described for the management of acute pain resulting from trauma and other inflammatory joint and soft tissue conditions.


Q: How long does it take for Voltarene tablets to reach their full effect?

A: According to official product information, immediate-release forms of Voltarene tablets are absorbed. They generally reach their highest concentration in the bloodstream within 1 to 2 hours after the dose is taken. This reflects when the active medicine is most available in the body.


Q: How long does the pain relief from Voltarene usually last?

A: The duration of pain relief depends on the specific Voltarene formulation being used. Official usage guidelines for the immediate-release oral tablets indicate that effects are managed by taking divided doses, in line with established administration frequency.


Q: Is it possible for Voltarene to affect blood pressure readings?

A: Yes, regulatory safety information indicates that Voltarene may be associated with changes in blood pressure. Both hypertension (elevated blood pressure) and fluid retention (edema) have been reported as adverse reactions.


Q: Are there known interactions between Voltarene and certain over-the-counter cold and flu medicines?

A: Official documents caution against taking Voltarene with other systemic Non-steroidal Anti-inflammatory Drugs (NSAIDs), which are sometimes found in over-the-counter cold and flu products. This is because combining them increases the potential risk of serious adverse events.


Q: Are there specific medical conditions, like inflammatory bowel disease, where Voltarene is not recommended?

A: Official documents state that Voltarene is strictly contraindicated for individuals with active gastrointestinal bleeding, perforation, or peptic ulcer disease. Official documents note the need for caution for those with a history of inflammatory bowel conditions due to the potential for serious gastrointestinal adverse events.


Q: Can Voltarene impact liver function test results?

A: Official safety labeling states that the drug may cause elevations in liver function tests (LFTs). In rare instances, severe liver reactions, including liver failure, have also been reported in clinical contexts.


Q: Is it true that Voltarene is only meant for short-term pain relief?

A: Regulatory guidance emphasizes using Voltarene for the shortest duration possible and at the lowest effective dose. This administration principle is in place to minimize the potential risk of serious side effects that may increase with the length of treatment.


Q: Are there specific foods or drinks that should be avoided when taking Voltarene?

A: Official labeling notes that the concurrent use of alcohol when taking Voltarene is discouraged. This combination is specifically linked to a significantly increased risk of serious gastrointestinal bleeding and ulceration.


Q: Are there documented cases of allergic reactions to Voltarene and what are the signs?

A: Official adverse reaction reports list common signs of allergy, such as skin rash, hives (urticaria), and itching (pruritus). The labeling also describes rare but severe allergic responses.


Q: Does Voltarene affect the way other pain medications work?

A: Official warnings state that taking Voltarene with Aspirin or other systemic Non-steroidal Anti-inflammatory Drugs (NSAIDs) is generally not recommended. This combination significantly increases safety risks, particularly the likelihood of serious gastrointestinal adverse events.


Q: What are the signs of a serious stomach issue related to Voltarene?

A: Official safety documents list specific signs of serious gastrointestinal issues. These warning signs include passing black or tarry stools, vomiting blood or material that looks like coffee grounds, or experiencing severe, persistent abdominal pain.


Q: Can Voltarene cause fluid retention or swelling in the ankles or legs?

A: Yes, official safety information lists fluid retention (edema) as a general adverse reaction. This condition can commonly appear as swelling in the hands, legs, or ankles.


Q: Is Voltarene a controlled substance or considered addictive?

A: Diclofenac (Voltarene) is classified as a Non-steroidal Anti-inflammatory Drug (NSAID). It is not classified as a federally controlled substance in major regulatory regions, nor is it associated with addiction.


Q: What is the evidence supporting Voltarene for specific types of chronic back pain?

A: Official indications for Voltarene include the management of the signs and symptoms of ankylosing spondylitis. This condition is a specific, chronic inflammatory disease affecting the joints and spine.


Q: Does applying Voltarene gel cause sensitivity to sunlight (photosensitivity)?

A: Yes, regulatory labeling for the topical gel formulation includes a warning about the potential for photosensitivity. This means the area where the gel is applied may experience an increased sensitivity to light when exposed to sunlight or UV radiation.


Q: Does Voltarene affect sleep or cause daytime drowsiness?

A: Common adverse reactions reported in regulatory documents include dizziness and headache. These effects may be observed by a patient, and they are listed as possible side effects.


Q: Is it normal to feel a temporary burning or itching sensation when applying Voltarene topical gel?

A: Yes, regulatory documents note that common side effects at the application site for the topical gel include rash, itching (pruritus), and dermatitis (skin inflammation). These local skin reactions may be felt as a temporary burning or itching sensation.


Q: Can Voltarene affect fertility or a person's ability to conceive?

A: Official regulatory documents indicate that the use of Voltarene may impair female fertility. Official guidance suggests that the medication is generally not recommended for women who are actively attempting to conceive.


Q: Does taking Voltarene cause weight gain over time?

A: The official safety information lists fluid retention (edema) as an adverse reaction. While this can cause temporary weight changes due to water retention, regulatory documents do not suggest that the drug causes long-term weight gain related to fat or muscle mass.


Q: What research evidence exists for using Voltarene to treat menstrual pain?

A: Official product documentation confirms that the drug is indicated and approved for the relief of pain associated with primary dysmenorrhea, which is the medical term for menstrual pain or cramping.

How should Voltarene be stored and disposed of?

How to Store and Dispose of Voltarene?

Voltarene (Diclofenac) requires specific handling defined by official regulatory instructions to ensure product stability and safety.

Storage and Handling Requirements

Requirement Type Official Guidance
Environment & Stability Store in a cool, dry place and keep protected from light and excessive heat. The container must be kept tightly closed and, for some forms, a limited shelf life applies after first opening.
Safety Precaution The medicine must be stored locked up and kept out of the sight and reach of children (a mandatory requirement based on regulatory classification).

Official Disposal Rules

Due to the environmental classification of Diclofenac, disposal must follow strict guidelines. Unused or expired Voltarene must be disposed of in accordance with local requirements using an approved pharmaceutical take-back program. It is formally forbidden to throw the product into household trash, flush it down the toilet, or discharge it into drains or wastewater systems.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Voltarene found in:

A-Z Index: